Compliances certificate under Reg 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dipna Pharmachem Ltd has submitted a compliance certificate to BSE for the quarter ended 30 September 2025, as required under SEBI's Regulation 74(5). The company's Registrar and Share Transfer Agent, Bigshare Services Private Limited, confirmed that the regulation is not applicable for this quarter. This is because 100% of the company's shares are already held in demat form, and no requests for rematerialisation or dematerialisation were received during the quarter (1 July to 30 September 2025). The certificate was signed by Managing Director Keyur Dipakkumar Shah on 10 October 2025.
This is a routine quarterly regulatory compliance filing with no impact on shareholders or the stock price. It simply confirms that all shares are in demat form and there were no share conversion requests during the quarter.